A first-in-human phase 1 clinical study of achn-975, a first-in-class agent being developed for the treatment of serious multidrug-resistant gram-NEG
Ended Cooperative Agreement Awarded
- Award ID
- W81XWH1220040
- Recipient
-
Achaogen, Inc. UEI KCRBSNJMBVW9
- Awarding agency
-
Department of the Army
Department of Defense
- Obligated
- $2,499,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Funding agency
- Department of Defense
- Place of performance
- South San Francisco, CA 94080, USA
Award details come from USAspending.gov.
Quick answers
Who received award W81XWH1220040?
W81XWH1220040 was awarded to Achaogen, Inc. by Department of the Army (Department of Defense) on May 7, 2012.
How much is award W81XWH1220040 worth?
$2,499,000 has been obligated on W81XWH1220040.
Which agency awarded W81XWH1220040?
Department of the Army (Department of Defense) awarded W81XWH1220040, with funding from Department of Defense.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award